Medical News

RSS

Cardiovascular strength may protect us from cognitive impairment as we age

Exercising to improve our cardiovascular strength may protect us from cognitive impairment as we age, according to a new study by researchers at the University of Montreal and its affiliated Institut universitaire de g-ratrie de Montr-al Research Centre.

25 Aug 2014

UAB scientist receives R01 grant to study transmission of deadly bacteria from mothers to infants

New research from the University of Alabama at Birmingham School of Optometry will study the transmission of a bacteria that up to 40 percent of healthy women carry, which becomes deadly when passed on to infants during birth.

25 Aug 2014

Half-glass rule can limit alcohol consumption

Sticking to a general rule of pouring just a half glass of wine limits the likelihood of overconsumption, even for men with a higher body mass index.

25 Aug 2014

Sanofi, Regeneron present alirocumab Phase 3 trial results at ESC Congress 2014

Regeneron Pharmaceuticals, Inc. and Sanofi today announced that details from four pivotal trials in the alirocumab ODYSSEY clinical program will be presented on Sunday, August 31, during a Hot Line session at ESC Congress 2014 in Barcelona, Spain, the world's largest cardiology meeting.

25 Aug 2014

Viewpoints: Employers and health benefits; Sen. Pryor's ACA endorsement; waging war on hep C

Most of the political class seems to have decided that ObamaCare is working well enough, the opposition is fading, and the subsidies and regulation are settling in as the latest wing of the entitlement state.

25 Aug 2014

Aldea Pharmaceuticals announces closure of $24M Series B equity financing

Aldea Pharmaceuticals, a company pioneering novel therapeutics to treat aldehyde metabolism disorders, today announced that it has closed a $24 million Series B equity financing.

25 Aug 2014

State highlights: Only 1/3 chose Medicaid plan in Fla.; Calif. Prop 46 money

A selection of health policy stories from Florida, Oregon, California, New York, Missouri, Iowa, Illinois, Massachusetts, Minnesota and New Jersey.

25 Aug 2014

Actavis files ANDA for generic version of Neupro

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Rotigotine Extended-release Transdermal Film, 1 mg/24 hr, 2mg/24 hr, 3 mg/24hr, 4 mg/24 hr, 6mg/24hr, and 8 mg/24 hr.

25 Aug 2014

Religious employers are offered fix on birth control coverage

News outlets report that the regulations, expected to be published later today, will allow religious nonprofits -- and perhaps later religious business owners -- to notify the government that they object to providing contraception coverage. Federal officials would then arrange for the workers' insurance.

25 Aug 2014

Clinical study shows long-term effectiveness of Orthocell’s Ortho-ATI™ for treatment resistant tennis elbow

Regenerative medicine company Orthocell Limited has today released results from a long-term clinical study into its Ortho-ATI™ treatment for tennis elbow that provides evidence of the durability and long term success of this treatment.

25 Aug 2014

Health insurance reimbursement may determine cancer screening rates

A study published today indicates that people living in American states that offer higher Medicaid payments for office visits are more likely to have been screened for breast, cervical, and colorectal cancers than those in states giving lower levels of Medicaid support.

25 Aug 2014

ESAOTE launches MyLab™Six at European Society of Cardiology 2014

Esaote, one of the world’s leading manufacturers of medical diagnostic systems, is launching MyLab™Six, a fast, accurate and highly flexible enhanced ultrasound system at ESC (European Society of Cardiology, Barcelona, 30th August - 3rd September). Configured for an extensive range of applications, MyLab™Six delivers a premium quality, yet affordable, solution for shared ultrasound services across any busy clinical setting.

24 Aug 2014

ProMedica participates in innovative research into development of non-invasive treatment for BPH

ProMedica is participating in innovative research into the development of a safe, non-invasive treatment for BPH or enlarged prostate. BPH can block the flow of urine out of the bladder and cause bladder, urinary tract or kidney problems.

23 Aug 2014

Patient deaths raise questions about lethal doses in hospice

The Washington Post examines the deaths of some hospice patients who were not close to death but who received large doses of powerful pain-killers.

23 Aug 2014

Study finds a host of new clues on gene-environment interactions in Crohn's disease

A new study finds a wide range of epigenetic changes-alterations in DNA across the genome that may be related to key environmental exposures-in children with Crohn's disease (CD), reports Inflammatory Bowel Diseases, official journal of the Crohn's & Colitis Foundation of America.

23 Aug 2014

Dr. Mark Rasak recognized with Diamond Lifetime Achievement Award in the field of Medicine

Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award in the field of Medicine as a result of his role as CEO of Cardiovascular Clinical Associates.

23 Aug 2014

Parsing the mixed messages regarding health plan costs

The Huffington Post breaks down the good and bad news surrounding what people may pay next year for coverage in the wake of the health law. Meanwhile, Modern Healthcare takes a look at how the Obama administration decision to let people keep health coverage that didn't comply with the overhaul's standards is impacting premium rates.

23 Aug 2014

SeraCare Life Sciences announces launch of new ACCURUN 501 C. difficile Control

SeraCare Life Sciences, a provider of high-quality biological materials that help optimize diagnostic performance, reliability and repeatability across the IVD lifecycle, today announced the launch of its new ACCURUN 501 C. difficile Control – the company's first molecular control product targeting hospital acquired infections.

23 Aug 2014

Arthrosurface's KISSloc Suture System receives FDA approval

Arthrosurface, Inc., a developer of novel joint technologies, has received FDA 510(k) clearance for the KISSloc Suture System, a mini plate and suture implant intended for the correction of a Hallux Valgus deformity.

23 Aug 2014

Seniors are less able to afford prescriptions, study finds

In its first few years, Medicare's Part D prescription drug program helped seniors pay for their medications, but that trend appears to be reversing, researchers found. Meanwhile, drugmakers fight over the rules for naming cheaper versions of biologic drugs.

23 Aug 2014